Same Contrast Dose, Different Risk of Kidney Injury, Depending on Procedure

The risk of contrast induced kidney injury is significantly lower in patients receiving transcatheter aortic valve replacement (TAVR) compared against patients getting a coronary angiography or angioplasty. 

Una nueva molécula para evitar la nefropatía por contraste

This is true even for valvular heart disease patients with higher risk profiles. 

Differences in contrast-induced acute kidney injury between TAVR or coronary patients had not been previously investigated.

This study published in J Am Heart Assoc retrospectively looked at patients undergoing elective TAVR and coronary procedures focusing especially in pre, and post-procedure kidney function. 

Contrast induced acute kidney injury (CI-AKI) was defined as relative increase in serum creatinine concentration of at least 0.3 mg/dL within 72 hours of contrast-medium administration compared with baseline. The study compared the incidence of CI-AKI after TAVR and coronary procedures.


Read also: Do We Need to See a Cardiologist before a Carotid Endarterectomy?


After excluding emergency procedures and patients in dialysis, 489 of the remaining patients received TAVR and 488 received coronary procedures. 

Patients undergoing TAVR resulted older, with more incidence of anemia and kidney deterioration (p<0.001 for all comparisons). TAVR patients consistently presented lower glomerular filtration and higher creatinine. 

Despite all the above mentioned, TAVR patients consistently presented lower CI-AKI vs. coronary patients (6.7% versus 14.5%, p<0.001).


Read also: Evidence or Theory? Antiaggregation Scheme after Peripheral Vascular Intervention.


After multivariable analysis, TAVR resulted an independent protection factor against post procedural CI-AKI. These outcomes were confirmed after propensity score matching. 

Conclusion

CI-AKI occurred less frequently in patients undergoing TAVR vs. coronary patients. The impact of contrast medium in TAVR patients might be better tolerated due to the hemodynamic changes that take place after valve implantation. 

JAHA-120-017194free

Original Title: Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions.

Reference: Gabriele Venturi et al. J Am Heart Assoc. 2020;9:e017194. DOI: 10.1161/JAHA.120.017194.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

TCT 2024 – EVOLVED trial: Early Intervention for Patients with Severe Asymptomatic Aortic Stenosis and Myocardial Fibrosis?

Treating symptomatic severe aortic stenosis (AS) with aortic valve replacement is currently considered a class I recommendation, evidence level B, according to the current...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...